©The Author(s) 2025.
World J Gastroenterol. Dec 7, 2025; 31(45): 113848
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.113848
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.113848
Table 1 Indications for peritoneovenous shunt placement
| Indication for PVS placement |
| Ascites refractory to medical treatment |
| Multiple CART or multiple abdominal paracenteses performed |
| Contraindication |
| Presence of bacterial peritonitis |
| Positive findings of endotoxin and bacteria in ascitic fluid |
| White blood cell counts in ascitic fluid of 500/μL or higher |
| Patients requiring caution |
| Patients with concurrent heart failure or pulmonary edema |
| Patients with significantly impaired liver function (Child-Pugh score of 14 or higher) |
| Patients with severe renal dysfunction |
| PS 2 or higher |
- Citation: Hamaguchi A, Ueda J, Taniai N, Yoshioka M, Matsushita A, Mizutani S, Kawano Y, Shimizu T, Kanda T, Murokawa T, Takata H, Furuki H, Aoki Y, Kawashima M, Irie T, Ono T, Haruna T, Yoshimori D, Yoshida H. Prognostic factors for peritoneovenous shunt placement for refractory ascites in liver cirrhosis. World J Gastroenterol 2025; 31(45): 113848
- URL: https://www.wjgnet.com/1007-9327/full/v31/i45/113848.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i45.113848